Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2017

WASHINGTONOct. 3, 2017 /PRNewswire/ — The Antimicrobials Working Group (AWG) today announced that thirteen of its member companies will present data from their clinical and research programs at IDWeek 2017 taking place in San Diego from October 4 – 8. In addition to 59 poster presentations, representatives from AWG member companies will be participating in various panels and symposiums addressing the current state of the antimicrobial development pipeline.

IDWeek is an annual scientific meeting that brings together infectious disease professionals to present and discuss the latest approaches in prevention, diagnosis, treatment, and epidemiology of infectious diseases.

“AWG is proud to share data from our member companies at IDWeek this year,” said Jeffrey Stein, Ph.D., president and chief executive officer of Cidara Therapeutics and Chairman of the AWG. “AWG member presentations span topics from preclinical and clinical studies on new antibacterial and antifungal drugs to the diagnostics of and research on emerging resistant bacterial and fungal pathogens. These presentations highlight the latest developments in the fight against superbugs and drug resistant infections.”

For more information on AWG member company posters and participation please visit:

About The Antimicrobials Working Group

AWG was founded in 2012 with the vision of utilizing collective power to improve the regulatory, investment, and commercial environment for emerging antibiotics and antifungal companies. Today, AWG is comprised of fifteen antimicrobials and diagnostics companies: Amplyx Pharmaceuticals, Aridis Pharmaceuticals, Arsanis Inc., Cempra Inc., Cidara Therapeutics Inc., ContraFect Corporation, Iterum Therapeutics Ltd., Melinta Therapeutics Inc., Nabriva Therapeutics US Inc., Paratek Pharmaceuticals Inc., SCYNEXIS Inc., T2 Biosystems Inc., Theravance Biopharma U.S. Inc., Viamet Pharmaceuticals Inc., and Zavante Therapeutics Inc. For more information, please visit

SOURCE Antimicrobials Working Group (AWG)

Related Links